GB Patent

GB0102239D0 — Methods of chemical synthisis

Assigned to Cancer Research Ventures Ltd · Expires 2001-03-14 · 25y expired

What this patent protects

This invention pertains to novel methods for the synthesis of certain nitrogen mustard prodrugs, such as N-{4-[N,N-bis(2-haloethylamino)-phenoxycarbonyl}-L-glutamic acid: wherein: X<SUP>2 </SUP>is a halo group, and is -F, -Cl, -Br, or -I; n is an integer from 0 to 4; …

USPTO Abstract

This invention pertains to novel methods for the synthesis of certain nitrogen mustard prodrugs, such as N-{4-[N,N-bis(2-haloethylamino)-phenoxycarbonyl}-L-glutamic acid: wherein: X<SUP>2 </SUP>is a halo group, and is -F, -Cl, -Br, or -I; n is an integer from 0 to 4; and, each R<SUP>A </SUP>is an aryl substituent. The methods comprise, at least, the steps of: glutamate conjugation (GC); silyloxy deprotection (SD); and, sulfonic esterification (SU). Certain preferred methods comprise the steps of: amine substitution (AS); silyloxy protection (SP); phenolic deprotection (PD); activation (AC); glutamate conjugation (GC); silyloxy deprotection (SD); sulfonic estenfication (SU); halogenation (HL); glutamate deprotection (GD); and glutamic acid protection (GP).

Drugs covered by this patent

Patent Metadata

Patent number
GB0102239D0
Jurisdiction
GB
Classification
Expires
2001-03-14
Drug substance claim
No
Drug product claim
No
Assignee
Cancer Research Ventures Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.